Cowden syndrome (CS), also known as multiple hamartomas syndrome, is a rare hereditary autosomal dominant disorder caused by a germline mutation in the phosphatase and tensin homolog (PTEN) gene mapped on chromosome 10. The clinical features of CS are variable, primarily presenting as mucocutaneous lesions (99%). A mucocutaneous lesion, such as trichilemmoma of the face or keratosis of the extremities, is an important diagnostic marker for CS. CS has been reported to increase the incidence of benign and malignant neoplasms in the breast, thyroid, and gastrointestinal tract. The risk of developing malignancy in individuals with CS is up to 10 times higher than general population throughout an entire life time.
INTRODUCTION
Cowden syndrome (CS), or multiple hamartoma syndrome, is a rare hereditary autosomal dominant disorder caused by a mutation in the phosphatase and tensin homolog (PTEN) gene on chromosome 10 with characteristic hamartoma of multiple organs [1] [2] [3] . PTEN is a tumor suppressor gene that controls phosphate, which mediates proliferation, progression, and apoptosis in the cell proliferation [4] . The incidence of CS is 1/200,000 individuals, and this syndrome is very difficult to diagnose clinically. The clinical features of CS are variable, presenting primarily as mucocutaneous lesions (99%). A mucocutaneous lesion, such as trichilemmoma of the face or keratosis of the extremities, is an important diagnostic marker for CS [5, 6] . CS has been reported to increase the incidence of benign and malignant neoplasms in the breast, thyroid, and gastrointestinal tract [1] [2] [3] 7] . The risk of developing breast cancer is up to 10 times higher in individuals with CS than in the general population throughout an entire life time [8] . The risk of developing breast cancer is up to 25%-50% times higher in individuals with CS than in the general population. Herein, we present a case of CS with synchronous bilateral breast cancer.
CASE REPORT
A 27-year-old woman presented with ill-defined firm masses in both breasts without palpable axillary nodes. She had no family history of breast carcinoma. However, she was previously diagnosed with CS at the age of 16 years. She had macrocephaly and multiple polyps in the oral cavity, pharynx, and gastrointestinal tract, as well as benign breast tumors and a nodular goiter of the thyroid gland when diagnosed. She underwent a right lobectomy of the thyroid gland and both breast masses were excised at the age of 18 years. Histologically, the right thyroid mass revealed follicular adenoma with atypia. The pathologic analysis of the bilateral breast masses in both breasts indicated a phyllodes tumor and tubular adenoma. She was followed up with breast ultrasonography every 1-2 years; an imaging study showed multiple Breast Imaging-Reporting and Data System (BI-RADS) category 3 masses in both breasts that had not changed. Nevertheless, at the age of 27 years, she again presented with masses in both breasts.
Physical examination revealed multiple 2.5 cm-sized ill-defined and firm masses in the upper outer quadrant of both breasts without palpable axillary lymph nodes. Mammography and breast ultrasonography were performed, and they showed that segmentally distributed Cowden Syndrome with PTEN Mutation in Breast Cancer 81 went ultrasonography-guided core biopsies of the suspicious lesions in both breasts, the pathologic report revealed ductal carcinoma in situ (DCIS) of both breasts. To decide on surgery, we performed breast magnetic resonance imaging, which revealed diffusely distributed, heterogenous, and nodular non-mass enhancement of approximately a 9.0-cm sized area in both breast upper outer quadrants ( Figure 1E and 1F). According to this finding, we performed the bilateral skin-sparing mastectomy with immediate breast reconstruction.
Breast reconstruction was performed using implants by plastic surgeons.
The final pathologic report showed that macroscopically, bilateral breast tissues bilaterally showed ill-demarcated, pale tan, and diffuse Table 2 [9].
CS is suspected if a person meets three major criteria which must include either macrocephaly, Lhermitte-Duclos disease [10] , or gastroin- Wild type Mutant
